Tristel Investor
Tristel proprietary chlorine dioxide (ClO₂): providing high-level disinfection in medical, pharmaceutical, veterinary and laboratory settings.
Headquarters:
Snailwell, United Kingdom
Funding Status:
IPO
Employee Number:
51-100
Estimated Revenue:
$10M to $50M
Investment Stage:
Undisclosed
Number Of Exists:
N/A
Investor Type:
N/A
Investors Number:
2
Founded Date:
1998-01-01
Industry:
Manufacturing, Medical Device